Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes

被引:37
|
作者
Jasir, A [1 ]
Schalén, C [1 ]
机构
[1] Univ Lund, Dept Med Microbiol, S-22362 Lund, Sweden
关键词
D O I
10.1093/jac/41.1.135
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Two hundred selected Swedish clinical strains of Streptococcus pyogenes, identified as erythromycin-resistant and isolated between 1980 and 1988, and 37 consecutive, resistant strains from 1989-90 were examined for resistance phenotype by disc diffusion. Strains constitutively resistant to macrolides, lincosamides and streptogramin B were absent in 1980-85 but accounted for 10% in 1986-88. The majority of the isolates belonged to a recently reported, non-inducible phenotype, described as having low-level resistance to erythromycin and sensitivity to clindamycin (82% in 1980-85, 50% in 1986-88). A significant proportion of the isolates did not agree with any known phenotype and therefore were considered as having one of three novel resistance subphenotypes. Most of the 37 strains from 1989-90 belonged to a novel subphenotype.
引用
收藏
页码:135 / 137
页数:3
相关论文
共 50 条
  • [1] Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes
    Cascone, C
    Santagati, M
    Noviello, S
    Iannelli, F
    Esposito, S
    Pozzi, G
    Stefani, S
    [J]. MICROBIAL DRUG RESISTANCE, 2002, 8 (02) : 129 - 132
  • [2] Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae
    Angot, P
    Vergnaud, M
    Auzou, M
    Leclercq, R
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (10) : 755 - 758
  • [3] Macrolide Resistance Phenotypes and Genotypes in French Clinical Isolates of Streptococcus pneumoniae
    P. Angot
    M. Vergnaud
    M. Auzou
    R. Leclercq
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 755 - 758
  • [4] Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America
    Hoban, DJ
    [J]. JOURNAL OF CHEMOTHERAPY, 2002, 14 : 25 - 30
  • [5] Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain
    Portillo, A
    Lantero, M
    Gastañares, MJ
    Ruiz-Larrea, F
    Torres, C
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 13 (02) : 137 - 140
  • [6] Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
    Descheemaeker, P
    Chapelle, S
    Lammens, C
    Hauchecorne, M
    Wijdooghe, M
    Vandamme, P
    Ieven, M
    Goossens, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (02) : 167 - 173
  • [7] Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece
    Petinaki, E
    Kontos, F
    Pratti, A
    Skulakis, C
    Maniatis, AN
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (01) : 67 - 70
  • [8] Streptococcus pyogenes isolated in Portugal:: Macrolide resistance phenotypes and correlation with T types
    Melo-Cristino, J
    Fernandes, ML
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1999, 5 (03): : 219 - 225
  • [9] GENETICS OF RESISTANCE TO MACROLIDE ANTIBIOTICS AND LINCOMYCIN IN NATURAL ISOLATES OF STREPTOCOCCUS-PYOGENES
    MALKE, H
    [J]. MOLECULAR & GENERAL GENETICS, 1974, 135 (04): : 349 - 367
  • [10] SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes
    Ripa, S
    Zampaloni, C
    Vitali, LA
    Giovanetti, E
    Montanari, MP
    Prenna, M
    Varaldo, PE
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2001, 7 (01): : 65 - 71